A detailed history of Bank Of America Corp transactions in Cytokinetics Inc stock. As of the latest transaction made, Bank Of America Corp holds 4,829,423 shares of CYTK stock, worth $234 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,829,423
Previous 4,380,769 10.24%
Holding current value
$234 Million
Previous $237 Million 7.43%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$51.22 - $60.16 $23 Million - $27 Million
448,654 Added 10.24%
4,829,423 $255 Million
Q2 2024

Aug 14, 2024

SELL
$47.86 - $75.05 $19 Million - $29.8 Million
-396,859 Reduced 8.31%
4,380,769 $237 Million
Q1 2024

May 15, 2024

BUY
$63.75 - $108.06 $288 Million - $487 Million
4,510,857 Added 1690.91%
4,777,628 $335 Million
Q4 2023

Feb 14, 2024

BUY
$26.88 - $83.49 $155,688 - $483,574
5,792 Added 2.22%
266,771 $22.3 Million
Q2 2023

Aug 14, 2023

SELL
$32.62 - $40.75 $30.7 Million - $38.4 Million
-942,276 Reduced 78.31%
260,979 $8.51 Million
Q1 2023

May 12, 2023

BUY
$33.36 - $45.71 $28.5 Million - $39 Million
854,101 Added 244.62%
1,203,255 $42.3 Million
Q4 2022

Feb 10, 2023

BUY
$35.77 - $51.11 $3.05 Million - $4.36 Million
85,215 Added 32.29%
349,154 $16 Million
Q3 2022

Nov 14, 2022

BUY
$38.54 - $54.52 $1.25 Million - $1.77 Million
32,463 Added 14.02%
263,939 $12.8 Million
Q2 2022

Aug 12, 2022

SELL
$33.93 - $48.92 $6.37 Million - $9.18 Million
-187,681 Reduced 44.78%
231,476 $9.09 Million
Q1 2022

May 16, 2022

BUY
$29.74 - $46.0 $3.7 Million - $5.72 Million
124,424 Added 42.22%
419,157 $15.4 Million
Q4 2021

Feb 08, 2022

BUY
$34.35 - $46.38 $2.17 Million - $2.93 Million
63,094 Added 27.24%
294,733 $13.4 Million
Q3 2021

Nov 15, 2021

SELL
$18.54 - $35.74 $255,166 - $491,889
-13,763 Reduced 5.61%
231,639 $8.28 Million
Q2 2021

Sep 13, 2021

BUY
$19.79 - $26.99 $4.86 Million - $6.62 Million
245,402 New
245,402 $4.86 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.57B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.